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Abstract—A series of aminophosphonates was synthesized, and their ability to carry alanine, a model hydrophilic molecule, across
phospholipid bilayer membranes was evaluated. Aminophosphonates facilitate the membrane transport at moderate rates, which
make them a suitable platform for the design of carriers for continuous drug release devices.
 2008 Elsevier Ltd. All rights reserved.
One of the most important challenges in designing lipo-
some based drug release systems is the precise control
of transport kinetics across bilayer boundaries.1,2 Encap-
sulated drugs should remain within liposomes during
storage, and release should only begin after the adminis-
tration. In an ideal system, a triggering event will initiate
continuous release with well-controlled rate. Synthetic
carriers of polar organic molecules through lipid bilayers
can potentially provide an elegant way to achieve this
goal. Insertion of carriers into bilayers of drug-contain-
ing liposomes immediately prior to administration would
trigger the release. Transport kinetics can be regulated by
varying the concentration of carriers in the bilayer.
Previously, a relatively small number of studies focused
on synthetic carriers for the transport of organic mole-
cules across bilayer lipid membranes compared to well
explored areas of artiﬁcial ion channels3,4 and transport
in supported liquid membranes.5–8 In the recent years,
however, the ﬁeld has been gaining considerable interest.
Several papers described synthetic carriers for carbohy-
drates,9,10 nucleosides,11 small peptides,12 and other
molecules.13,14 Among the most recent beautiful exam-
ples is the transport of oligonucleotides guided by um-
brella carriers in the innovative ‘needle and thread
concept’.15 Sunamoto et al. reported on the transport
of phenylalanine using a photoresponsive carrier.16
Traditionally, high selectivity and fast transport rates
were viewed as desirable albeit challenging. These char-
acteristics may not be necessary in the design of carriers
suitable for continuous drug release. This application re-
quires slow release of a single component over a long
period of time, measured between hours and weeks,
and neither selectivity nor fast transport is critical. In
fact, slow carriers are likely to have an advantage of
inherently low cytotoxicity, an important safety consid-
eration in the case a carrier molecule separates from a
liposome and inserts into a cellular membrane. Small
size of carriers is likely to be beneﬁcial for rapid incorpo-
ration into the liposomal bilayer.
Considering the above, we decided to synthesize and
evaluate a series of a-aminophosphonates as carriers
of hydrophilic organic molecules across phospholipid
membranes. We used alanine, an amino acid, as a model
hydrophilic bifunctional molecule for transport studies.
In our view, aminophosphonates are excellent carrier
platforms. They possess two binding sites, a hydrogen
bond donor and a hydrogen bond acceptor suitable
for two-point binding of hydrophilic molecules creating
in the case of amino acids a complex with hydrophobic
exterior.17,18 They are readily prepared in a one-pot syn-
thesis by the Kabachnik–Fields reaction from a primary
amine, a phosphite, and a carbonyl compound.19,20
Their hydrophilic–hydrophobic balance can be easily
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